A carregar...
A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene
BACKGROUND: Lung cancer is the leading cause of cancer-related death worldwide. Epidermal growth factor receptor (EGFR) - tyrosine kinase inhibitor (TKI) is used for the patients with EGFR-mutant lung cancer. Recently, phase III studies in the patients with EGFR-mutant demonstrated that EGFR-TKI mon...
Na minha lista:
Main Authors: | , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
BioMed Central
2012
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3515412/ https://ncbi.nlm.nih.gov/pubmed/23181703 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-558 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|